Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Bruce, McGarity"'
Autor:
Paul J. Clark, Patricia C. Valery, James Ward, Simone I. Strasser, Martin Weltman, Alexander Thompson, Miriam T. Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, Wendy Cheng, Geoff Farrell, Stuart K. Roberts
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background First Nations Peoples of Australia are disproportionally affected by hepatitis C (HCV) infection. Through a prospective study we evaluated the outcome of direct-acting antiviral (DAA) therapy among First Nations Peoples with HCV i
Externí odkaz:
https://doaj.org/article/c756cff2c64949afbd083b0f41c57a38
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Medication charting errors occur often and can be harmful for patients. Interventions to improve charting errors have demonstrated some success particularly if the intervention uses multiple approaches including an education compo
Externí odkaz:
https://doaj.org/article/a30fe4665e32419f8d07dd8fd151c7c2
Autor:
Paul J. Clark, Patricia C. Valery, Simone I. Strasser, Martin Weltman, Alexander J. Thompson, Miriam Levy, Barbara Leggett, Amany Zekry, Julian Rong, Peter Angus, Jacob George, Steven Bollipo, Bruce McGarity, William Sievert, Gerry Macquillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Geoff Chu, Damian Harding, Wendy Cheng, Geoff Farrell, Stuart K. Roberts
Publikováno v:
Digestive Diseases and Sciences. 68:291-303
In 2016, direct-acting antiviral (DAA) treatment for hepatitis C (HCV) became available through Australia's universal health care system, with the aim of HCV elimination. We report real-world effectiveness of DAA HCV treatment in Australia from a cli
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Health Services Research
BMC Health Services Research
Background Medication charting errors occur often and can be harmful for patients. Interventions to improve charting errors have demonstrated some success particularly if the intervention uses multiple approaches including an education component. The
Autor:
Mazhar M Haque, K. New, Alan Wigg, Simone I. Strasser, Jacinta O'Keefe, Bruce McGarity, James O'Beirne, Ivan Valiozis, Miriam T. Levy, Mark Wilson, Zina Valaydon, Margaret Hellard, Rohit Sawhney, Scott Bowden, Martin Weltman, Emily Prewett, Gerry MacQuillan, Siddharth Sood, Timothy Papaluca, Edmund Tse, Mark W. Douglas, William Sievert, Leslie Fisher, Katherine A. Stuart, Gregory J. Dore, Alexander J. Thompson, Marie Sinclair, Amanda Wade, James Thomas, Jacob George, Golo Ahlenstiel, Simon Hazeldine, Joseph Doyle, Mark Stoove, Stuart K. Roberts, Aidan J. Woodward, Geoffrey C. Farrell
Publikováno v:
Clin Infect Dis
Background In clinical trials, hepatitis C virus (HCV) salvage treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) achieved an SVR12 rate of >95% in NS5A-experienced participants. Lower SVR12 rates have been reported in real-world studie
Autor:
Isuru, Ranasinghe, Chris, Naoum, Bernadette, Aliprandi-Costa, Andrew P, Sindone, P Gabriel, Steg, John, Elliott, Bruce, McGarity, Jeffrey, Lefkovits, David, Brieger, Jonathon, Waites
Publikováno v:
European journal of heart failure. 14(5)
Aim The outcome of patients with chronic heart failure (CHF) following an ischaemic event is poorly understood. We evaluated the management and outcomes of CHF patients presenting with an acute coronary syndrome (ACS) and explored changes in outcomes
Autor:
Henry Lau, Andrew S. Jordan, Bruce McGarity, Gerard Ozorio, Haesung Bak, Catherine S. Marshall
Publikováno v:
The Medical journal of Australia. 187(9)
Autoimmune hepatitis is a rare but increasingly recognised serious complication of treatment with the tumour necrosis factor-alpha (TNF-alpha) blocking agent, infliximab. This report adds to the small but growing number of articles describing this si
Autor:
Andrew Sindone, Jeffrey Lefkovits, Isuru Ranasinghe, John Elliott, B. Aliprandi-Costa, Bruce McGarity, Christopher Naoum, David Brieger
Publikováno v:
Heart, Lung and Circulation. 18:S189-S190
Autor:
Vincent T. K. Chow, J. Counsell, David Brieger, B. Aliprandi-Costa, Gerry Devlin, Craig P. Juergens, Isuru Ranasinghe, Bruce McGarity
Publikováno v:
Heart, Lung and Circulation. 18:S118
Autor:
Bruce McGarity, Christopher Naoum, B. Aliprandi-Costa, Jeffery Lefkovits, Gerry Devlin, Isuru Ranasinghe, Andrew Sindone, David Brieger
Publikováno v:
Heart, Lung and Circulation. 18:S184